Literature DB >> 27352981

Seronegative celiac disease: Shedding light on an obscure clinical entity.

Umberto Volta1, Giacomo Caio1, Elisa Boschetti1, Fiorella Giancola1, Kerry J Rhoden1, Eugenio Ruggeri1, Paola Paterini1, Roberto De Giorgio2.   

Abstract

BACKGROUND: Although serological tests are useful for identifying celiac disease, it is well established that a minority of celiacs are seronegative. AIM: To define the prevalence and features of seronegative compared to seropositive celiac disease, and to establish whether celiac disease is a common cause of seronegative villous atrophy.
METHODS: Starting from 810 celiac disease diagnoses, seronegative patients were retrospectively characterized for clinical, histological and laboratory findings.
RESULTS: Of the 810 patients, fourteen fulfilled the diagnostic criteria for seronegative celiac disease based on antibody negativity, villous atrophy, HLA-DQ2/-DQ8 positivity and clinical/histological improvement after gluten free diet. Compared to seropositive, seronegative celiac disease showed a significantly higher median age at diagnosis and a higher prevalence of classical phenotype (i.e., malabsorption), autoimmune disorders and severe villous atrophy. The most frequent diagnosis in the 31 cases with seronegative flat mucosa was celiac disease (45%), whereas other diagnoses were Giardiasis (20%), common variable immunodeficiency (16%) and autoimmune enteropathy (10%).
CONCLUSIONS: Although rare seronegative celiac disease can be regarded as the most frequent cause of seronegative villous atrophy being characterized by a high median age at diagnosis; a close association with malabsorption and flat mucosa; and a high prevalence of autoimmune disorders.
Copyright © 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmune disorders; Autoimmune enteropathy; Common variable immunodeficiency; Olmesartan; Seronegative celiac disease; Villous atrophy

Mesh:

Substances:

Year:  2016        PMID: 27352981     DOI: 10.1016/j.dld.2016.05.024

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  19 in total

1.  The CD That Pays Dividends: More Than 15 Years of Deamidated Gliadin Peptide Antibodies.

Authors:  Julio C Bai; Elena F Verdú
Journal:  Dig Dis Sci       Date:  2017-05       Impact factor: 3.199

2.  The impact of acid suppression medications and non-steroidal anti-inflammatory drugs on clinical and histologic features in celiac disease.

Authors:  Robyn Jordan; Sarah Shannahan; Suzanne K Lewis; Suneeta Krishnareddy; Daniel A Leffler; Peter H R Green; Benjamin Lebwohl
Journal:  Dig Liver Dis       Date:  2017-04-02       Impact factor: 4.088

3.  Celiac Disease Presenting in a Community-Based Gastroenterology Practice: Obesity and Bone Disease Are Common.

Authors:  Giovanni A Roldan; Sehrish Jamot; Krzysztof Kopec; Amber Charoen; Daniel Leffler; Edward R Feller; Samir A Shah
Journal:  Dig Dis Sci       Date:  2022-06-01       Impact factor: 3.199

Review 4.  Celiac Disease Revisited.

Authors:  João Calado; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2021-03-17

5.  Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study.

Authors:  Annalisa Schiepatti; Anupam Rej; Stiliano Maimaris; Simon S Cross; Petra Porta; Imran Aziz; Tim Key; John Goodwin; Amelie Therrien; Shakira Yoosuf; Daniel A Leffler; Jocelyn A Silvester; Catherine Klersy; Federico Biagi; David S Sanders
Journal:  Aliment Pharmacol Ther       Date:  2021-09-08       Impact factor: 8.171

Review 6.  Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?

Authors:  Enzo Ierardi; Giuseppe Losurdo; Andrea Iannone; Domenico Piscitelli; Annacinzia Amoruso; Michele Barone; Mariabeatrice Principi; Antonio Pisani; Alfredo Di Leo
Journal:  Ann Gastroenterol       Date:  2017-05-31

7.  Challenges in the celiac disease diagnosis; Prague consensus.

Authors:  Gabriel Samasca; Genel Sur; Iulia Lupan; Peter Makovicky; Hugh James Freeman
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

8.  Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet.

Authors:  Maria Pina Dore; Giovanni Mario Pes; Ivana Dettori; Vincenzo Villanacci; Alessandra Manca; Giuseppe Realdi
Journal:  BMJ Open Gastroenterol       Date:  2017-07-17

Review 9.  Pitfalls in the Diagnosis of Coeliac Disease and Gluten-Related Disorders.

Authors:  Annalisa Schiepatti; Jessica Savioli; Marta Vernero; Federica Borrelli de Andreis; Luca Perfetti; Antonio Meriggi; Federico Biagi
Journal:  Nutrients       Date:  2020-06-07       Impact factor: 5.717

Review 10.  The serological diagnosis of coeliac disease - a step forward.

Authors:  Geoffrey Holmes; Carolina Ciacci
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.